COLNE VALLEY GROUP PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: B85054 | HUDDERSFIELD, HD7 5JN
Showing results 151-200 of 656
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Insulin aspart | 317 | 2,174 | £16.2K | -16.7% ▼ |
| Risedronate sodium | 314 | 1,832 | £632 | +158.9% ▲ |
| Fentanyl | 313 | 3,145 | £10.9K | +205.5% ▲ |
| Ibuprofen | 309 | 29.2K | £1.2K | +153.6% ▲ |
| Fluticasone/umeclidinium/vilanterol | 306 | 372 | £15.7K | +30.5% ▲ |
| Alfuzosin hydrochloride | 302 | 9,970 | £3.4K | +322.2% ▲ |
| Aripiprazole | 299 | 6,926 | £1.1K | +17.5% ▲ |
| Sacubitril/valsartan | 297 | 18.5K | £30.2K | +24.0% ▲ |
| Other multivitamin preparations | 292 | 5,607 | £1.8K | +69.0% ▲ |
| Letrozole | 287 | 9,894 | £885 | +53.7% ▲ |
| 286 | 397 | £518 | +29.8% ▲ | |
| Pravastatin sodium | 280 | 10.3K | £471 | -13.8% ▼ |
| Fludrocortisone acetate | 279 | 4,289 | £829 | +164.5% ▲ |
| Pancreatin | 277 | 67.6K | £23.6K | +149.2% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 274 | 9,716 | £1.0K | +79.4% ▲ |
| 272 | 2,450 | £1.1K | +9.0% ▲ | |
| Sodium valproate | 268 | 35.5K | £6.0K | -15.7% ▼ |
| Tolterodine | 268 | 8,726 | £2.2K | +80.3% ▲ |
| Beclometasone dipropionate | 267 | 305 | £929 | +24.1% ▲ |
| Eplerenone | 263 | 7,636 | £929 | -0.8% vs avg |
| Carbamazepine | 262 | 25.6K | £2.1K | -11.7% ▼ |
| Methylphenidate hydrochloride | 258 | 9,966 | £11.0K | -0.1% vs avg |
| Lidocaine hydrochloride | 257 | 10.4K | £5.1K | +49.0% ▲ |
| Dexamethasone | 252 | 1,300 | £811 | +46.6% ▲ |
| Methylprednisolone acetate | 251 | 300 | £955 | +117.4% ▲ |
| Calcipotriol | 251 | 22.8K | £12.0K | +47.4% ▲ |
| Nebivolol | 249 | 7,574 | £1.6K | +134.9% ▲ |
| Sitagliptin | 243 | 8,827 | £584 | -37.7% ▼ |
| Fluconazole | 242 | 1,980 | £508 | +213.0% ▲ |
| Loratadine | 236 | 7,495 | £172 | +12.9% ▲ |
| Umeclidinium bromide | 232 | 286 | £7.5K | +276.4% ▲ |
| Pramipexole | 232 | 16.0K | £2.5K | +136.3% ▲ |
| Celecoxib | 232 | 12.6K | £697 | +251.3% ▲ |
| Biphasic isophane insulin | 229 | 1,740 | £7.6K | +105.3% ▲ |
| 224 | 107.6K | £1.4K | -15.1% ▼ | |
| Estradiol | 221 | 5,324 | £2.7K | -18.1% ▼ |
| Hydroxychloroquine sulfate | 220 | 8,406 | £428 | +13.6% ▲ |
| Nifedipine | 219 | 11.0K | £2.9K | +16.9% ▲ |
| Glimepiride | 217 | 10.9K | £318 | +135.2% ▲ |
| Fluticasone furoate | 217 | 243 | £1.8K | +12.0% ▲ |
| Lithium carbonate | 215 | 3,976 | £843 | +69.5% ▲ |
| Insulin glargine | 214 | 1,208 | £10.8K | -24.6% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 207 | 7,218 | £379 | -8.4% ▼ |
| Peppermint oil | 205 | 13.3K | £1.7K | +157.6% ▲ |
| Tadalafil | 203 | 5,178 | £1.0K | +19.4% ▲ |
| Azithromycin | 200 | 2,448 | £684 | +57.8% ▲ |
| Pioglitazone hydrochloride | 200 | 5,362 | £278 | +126.2% ▲ |
| Bimatoprost | 198 | 2,508 | £1.7K | +33.2% ▲ |
| Etoricoxib | 196 | 4,627 | £1.2K | +143.3% ▲ |
| Umeclidinium bromide/vilanterol | 192 | 262 | £8.1K | -1.5% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.